Teva to sell assets in global women ’s health business for $1.38bn

Teva Pharmaceutical Industries has entered two agreements to divest the remaining stake in its specialist global women ’s health business for $1.38bn.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Women